Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced outside the brain (early spermatids) | 0.10 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 1,178 | 0.91 |
| pathways Reactome | 39 pathways; mostly growth signalling | 0.60 |
No case: the score is under the bar. Receipt 11184
Sealed predictions
- FGF4 in dopamine neurons, braak+0.46 (p 0.214) → -0.32 (p 0.400)receipt 11192
Swarm cases
receipt 11192: FGF4 in dopamine neurons, braak
- power
- full sample +0.03 (p 0.901, n 18), 95% CI -0.44 to +0.49. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.11 (p 0.658, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.16 (p 0.532, n 18). could be the mix.
- skeptic
- leave-one-out range -0.09 to +0.15, sign flips 3; without severely affected donors +0.03 (p 0.901, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for FGF4 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts